Author

J. van Limbergen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:clustering· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Assay:metagenomics· 1

Frequent Co-Authors

A. Coffin· 1 shared A. Patel· 1 shared A. Shillings· 1 shared A. Y. F. Li Yim· 1 shared C. E. Blunt· 1 shared D. A. Zwijnenburg· 1 shared D. F. Tough· 1 shared D. J. Mitchell· 1 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Coffin

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologymSpherePeer-reviewedOct 28, 2020

Assessing the variation within the oral microbiome of healthy adults

J. T. Nearing, V. DeClercq, J. Van Limbergen, M. G. I. Langille

This study examines the oral microbiome of 1049 healthy adults to identify factors shaping microbial composition, finding that anthropometric and demographic factors have small individual impacts.

DOI 10.1128/msphere.00451-20

humanmetagenomics

𝕏 PostBluesky

ImmunologybioRxivAug 10, 2020

Modulation of macrophage inflammatory function through selective inhibition of the epigenetic reader protein SP140

M. Ghiboub, J. Koster, P. D. Craggs…·W. J. de Jonge

This study identifies SP140 as a druggable epigenetic reader and therapeutic target for Crohn's disease by showing that its inhibition reduces inflammatory macrophage activation and cytokine expression.

DOI 10.1186/s12915-022-01380-6

humanbulk RNA-seq

𝕏 PostBluesky